Valuation: Fresenius SE & Co. KGaA

Market Cap 26.03B 30.39B 24.36B 22.29B 41.84B 2,907B 42.39B 288B 112B 1,461B 114B 112B 4,831B P/E 2026 *
14.1x
P/E 2027 * 12.2x
Enterprise Value 36.46B 42.56B 34.11B 31.23B 58.6B 4,072B 59.38B 403B 157B 2,046B 160B 156B 6,766B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.43x
Free-Float
73%
Yield 2026 *
2.54%
Yield 2027 * 2.73%
1 day-1.65%
1 week-0.59%
Current month+6.42%
1 month+10.19%
3 months+17.95%
6 months-8.99%
Current year-3.27%
1 week 46.04
Extreme 46.035
47.98
1 month 42.68
Extreme 42.68
48.48
Current year 35.11
Extreme 35.11
52.96
1 year 35.11
Extreme 35.11
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
28/05/26 Buy

Chief Executive Officer

790 0.0001%
06/03/26 Buy

Chief Executive Officer

4,130 0.0007%
01/04/25 Fiscal year 850 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-0.59%+0.49%+62.37% 30.4B
-0.58%-4.21%+30.29%+38.74% 120B
+6.15%+6.13%+6.24%+56.28% 87.96B
+1.15%+3.95%+32.63%+83.36% 26.63B
-0.25%+4.12%-3.88%-9.17% 22.17B
+2.08%+3.61%+56.48%+287.51% 21.95B
+1.30%+1.52%-8.24%+13.98% 14.2B
-1.83%-2.19%-7.94%-8.92% 12.66B
-0.26%-2.89%+27.10%+71.62% 11.18B
-1.74%+8.46%+127.42%+2,036.36% 9.88B
Average +0.44%-0.50%+26.06%+263.21% 35.68B
Weighted average by Cap. +1.36%-0.59%+21.19%+114.42%

Financials

2026 *2027 *
Net sales 23.77B 27.75B 22.24B 20.36B 38.21B 2,655B 38.71B 263B 102B 1,334B 104B 102B 4,411B 24.98B 29.17B 23.38B 21.4B 40.16B 2,791B 40.69B 276B 108B 1,402B 110B 107B 4,637B
Net income 1.89B 2.2B 1.77B 1.62B 3.03B 211B 3.07B 20.87B 8.14B 106B 8.28B 8.1B 350B 2.16B 2.52B 2.02B 1.85B 3.46B 241B 3.51B 23.83B 9.29B 121B 9.45B 9.24B 400B
Net Debt 10.43B 12.17B 9.76B 8.93B 16.76B 1,165B 16.98B 115B 44.95B 585B 45.71B 44.71B 1,935B 9.61B 11.22B 8.99B 8.23B 15.45B 1,074B 15.65B 106B 41.43B 539B 42.13B 41.21B 1,784B
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA is a Germany-based healthcare group focused on products and services for the treatment of critically and chronically ill patients. The Company operates through its core businesses, Fresenius Kabi and Fresenius Helios. Fresenius Kabi develops and supplies biopharmaceuticals, clinical nutrition products, medical technologies, intravenously administered generic drugs, and infusion therapies. Fresenius Helios is Europe’s private healthcare provider, operating hospitals, outpatient centers, and other healthcare facilities in Germany, Spain, and Latin America. Fresenius also holds an investment in Fresenius Medical Care, a provider of dialysis products and services for patients with chronic kidney disease.
Employees
178,486
Date Price Change Volume
14/08/26 47.38 -0.59% 62,263
20/08/26 €46.22 -0.92% 637,439
19/08/26 €46.65 -0.18% 753,359
18/08/26 €46.73 -0.01% 695,683
17/08/26 €46.74 -0.73% 647,220
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
46.22EUR
Average target price
55.86EUR
Spread / Average Target
+20.87%

Quarterly revenue - Rate of surprise